Understand the source comparison
Peptides and Berberine Synergy Timing Protocol: Comparison
GLP-1 Agonists (semaglutide, tirzepatide) 30 minutes 500mg HCl GLP-1 receptor upregulation, AMPK-mediated insulin sensitivity 30–40% increase in receptor binding vs simultaneous dosing Strongest evidence. This is where peptides and berberine synergy timing pro
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GLP-1 Agonists (semaglutide, tirzepatide)
- 30 minutes
- 500mg HCl
- GLP-1 receptor upregulation, AMPK-mediated insulin sensitivity
- 30–40% increase in receptor binding vs simultaneous dosing
- Strongest evidence. This is where peptides and berberine synergy timing protocol shows clearest benefit
- Growth Hormone Secretagogues (CJC-1295, ipamorelin)
- 45–60 minutes (acute pulse); simultaneous (chronic IGF-1)
- IGF-1 receptor sensitivity in liver/muscle, enhanced GH pulse amplitude
- 15–25% increase in downstream IGF-1 signaling
- Moderate evidence. Timing matters more for acute protocols than daily maintenance
- Metabolic Peptides (MOTS-c, SS-31)
- Mitochondrial AMPK priming, NAD+ pathway activation
- 10–20% estimated (no direct trials)
- Theoretical synergy. Mechanistically sound but not yet quantified in published research
- Thymic Peptides (Thymalin, TB-500)
- Minimal interaction. Berberine optional
- 500mg HCl (if used)
- Anti-inflammatory effects on immune cell metabolism
- <10%. No direct receptor crosstalk
- Weak evidence. Berberine won't harm but likely won't meaningfully enhance thymic peptide activity